Advertisement

Der Internist

, Volume 50, Issue 7, pp 788–798 | Cite as

Definition, Epidemiologie und ökonomische Aspekte der Sepsis bei Erwachsenen

  • O. MoererEmail author
  • M. Quintel
Schwerpunkt: Sepsis

Zusammenfassung

Die Sepsis ist weltweit eine der Hauptursachen für Morbidität und Mortalität. Allein in Deutschland erkranken pro Jahr 75.000 Einwohner (110 von 100.000) an einer schweren Sepsis bzw. septischem Schock und 79.000 (116 von 100.000) an einer Sepsis. Die Erkrankung geht mit einem hohen Risiko für irreversibles Organversagen mit tödlichem Verlauf einher. Pro Jahr versterben ca. 60.000 Menschen, und bei den Überlebenden findet sich noch über Jahre eine reduzierte Lebensqualität. Aufgrund demographischer Veränderungen ist zukünftig mit einer Zunahme von Inzidenz und Gesamtletalität zu rechnen. Zudem verursacht die Sepsis eine hohe ökonomische Belastung. Eine frühzeitige und umfassende Therapie führt zu einer deutlichen Reduktion der Sterblichkeit. Umfassende Kenntnisse der Epidemiologie, Definitionen und Therapie der Sepsis sind die Voraussetzung für die Eindämmung der sepsisassoziierten Letalität. Ziel dieser Übersicht ist die Präsentation aktueller Definitionen sowie der Epidemiologie und Kosten der Sepsis.

Schlüsselwörter

Sepsis Schwere Sepsis Septischer Schock Kosten Epidemiologie 

Sepsis in adult patients – definitions, epidemiology and economic aspects

Abstract

Worldwide, sepsis is one of the leading causes of morbidity and mortality. In Germany about 79,000 (116/100,000) suffer from sepsis, and the incidence of severe sepsis and septic shock is about 75,000 cases per year. Patients are at high risk for irreversible organ failure and a lethal course. About 60,000 die from sepsis annually, and survivors have a reduced quality of life. It is presumed that demographic changes will lead to an increased incidence and overall mortality in the future. Additionally sepsis imposes a considerable economic burden to the society. Early and comprehensive treatment significantly improves outcome. An increased knowledge and awareness about the epidemiology, definitions and therapy of sepsis might contribute to the improved outcome. This review aims to present information on current definitions, epidemiology and the economic burden of sepsis.

Keywords

Sepsis Severe Sepsis Septic shock Cost Epidemiology 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Alberti C, Brun-Buisson C, Burchardi H et al. (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28: 108–121PubMedCrossRefGoogle Scholar
  2. 2.
    Alberti C, Brun-Buisson C, Chevret S et al. (2005) Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 171: 461–468PubMedCrossRefGoogle Scholar
  3. 3.
    Alberti C, Brun-Buisson C, Goodman SV et al. (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168: 77–84PubMedCrossRefGoogle Scholar
  4. 4.
    Angus DC, Linde-Zwirble WT, Clermont G et al. (2003) Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 31: 1–11PubMedCrossRefGoogle Scholar
  5. 5.
    Angus DC, Linde-Zwirble WT, Lidicker J et al. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–1310PubMedCrossRefGoogle Scholar
  6. 6.
    Angus DC, Wax RS (2001) Epidemiology of sepsis: An update. Crit Care Med 29: S109–S116PubMedCrossRefGoogle Scholar
  7. 7.
    Azoulay E, Alberti C, Legendre I et al. (2005) Post-ICU mortality in critically ill infected patients: An international study. Intensive Care Med 31: 56–63PubMedCrossRefGoogle Scholar
  8. 8.
    Beovic B, Hladnik Z, Pozenel P, Siuka D (2008) Epidemiology of severe sepsis in Slovenian intensive care units for adults. J Chemother 20: 134–136PubMedGoogle Scholar
  9. 9.
    Bernard GR, Vincent JL, Laterre PF et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709PubMedCrossRefGoogle Scholar
  10. 10.
    Blanco J, Muriel-Bombin A, Sagredo V et al. (2008) Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study. Crit Care 12: R158PubMedGoogle Scholar
  11. 11.
    Boldt J, Papsdorf M (2005) Expensive modern therapy options in intensive care medicine in Germany – are they being used? Results of a questionnaire. Dtsch Med Wochenschr 130: 87–91PubMedCrossRefGoogle Scholar
  12. 12.
    Bone RC (1991) A critical evaluation of new agents for the treatment of sepsis. JAMA 266: 1686–1691PubMedCrossRefGoogle Scholar
  13. 13.
    Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24: 1125–1128PubMedCrossRefGoogle Scholar
  14. 14.
    Bone RC, Balk RA, Cerra FB et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644–1655PubMedCrossRefGoogle Scholar
  15. 15.
    Chalfin DB (1995) Cost-effectiveness analysis in health care. Hosp Cost Manag Account 7: 1–8PubMedGoogle Scholar
  16. 16.
    Cheng B, Xie G, Yao S et al. (2007) Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 35: 2538–2546PubMedCrossRefGoogle Scholar
  17. 17.
    Clade H (2004) Kompetenzzentren sind zukunftsträchtig. Das neue Finanzierungssystem im Akutkrankenhaus zwingt zur internen Umstrukturierung und zum Denken in Funktionen. Dtsch Ärztebl 41: 2724–2726Google Scholar
  18. 18.
    Dellinger RP, Levy MM, Carlet JM et al. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296–327PubMedCrossRefGoogle Scholar
  19. 19.
    Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 35: 1244–1250PubMedCrossRefGoogle Scholar
  20. 20.
    Edbrooke DL, Hibbert CL, Kingsley JM et al. (1999) The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med 27: 1760–1767PubMedCrossRefGoogle Scholar
  21. 21.
    Edbrooke DL, Ridley SA, Hibbert CL, Corcoran M (2001) Variations in expenditure between adult general intensive care units in the UK. Anaesthesia 56: 208–216PubMedCrossRefGoogle Scholar
  22. 22.
    Engel C, Brunkhorst FM, Bone HG et al. (2007) Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med 33: 606–618PubMedCrossRefGoogle Scholar
  23. 23.
    Esteban A, Frutos-Vivar F, Ferguson ND et al. (2007) Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward. Crit Care Med 35: 1284–1289PubMedCrossRefGoogle Scholar
  24. 24.
    Finfer S, Bellomo R, Lipman J et al. (2004) Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 30: 589–596PubMedCrossRefGoogle Scholar
  25. 25.
    Flaatten H (2004) Epidemiology of sepsis in Norway in 1999. Crit Care 8: R180–R184PubMedCrossRefGoogle Scholar
  26. 26.
    Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26: 2078–2086PubMedCrossRefGoogle Scholar
  27. 27.
    From the Centers for Disease Control (1990) Increase in National Hospital Discharge Survey rates for septicemia – United States, 1979–1987. MMWR Morb Mortal Wkly Rep 39: 31–34Google Scholar
  28. 28.
    Gasparovic V, Gornik I, Ivanovic D (2006) Sepsis syndrome in Croatian intensive care units: Piloting a national comparative clinical database. Croat Med J 47: 404–409PubMedGoogle Scholar
  29. 29.
    Harrison DA, Welch CA, Eddleston JM (2006) The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: Secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 10: R42PubMedCrossRefGoogle Scholar
  30. 30.
    Heyland DK, Hopman W, Coo H et al. (2000) Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life. Crit Care Med 28: 3599–3605PubMedCrossRefGoogle Scholar
  31. 31.
    Ibrahim I (2008) It is time to label sepsis as a public health problem. J Crit Care 23: 452–453PubMedCrossRefGoogle Scholar
  32. 32.
    Karlsson S, Varpula M, Ruokonen E et al. (2007) Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: The Finnsepsis study. Intensive Care Med 33: 435–443PubMedCrossRefGoogle Scholar
  33. 33.
    Kubler A, Durek G, Zamirowska A et al. (2004) Severe sepsis in Poland – results of internet surveillance of 1043 cases. Med Sci Monit 10: CR635–CR641PubMedGoogle Scholar
  34. 34.
    Levy MM, Fink MP, Marshall JC et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250–1256PubMedCrossRefGoogle Scholar
  35. 35.
    Lucioni C, Mazzi S, Currado I (2001) Sepsis costs in Italy. Intensive Care Med 27: 284Google Scholar
  36. 36.
    Manns BJ, Lee H, Doig CJ et al. (2002) An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 347: 993–1000PubMedCrossRefGoogle Scholar
  37. 37.
    Martin CM, Priestap F, Fisher H et al. (2009) A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry. Crit Care Med 37: 81–88PubMedCrossRefGoogle Scholar
  38. 38.
    Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546–1554PubMedCrossRefGoogle Scholar
  39. 39.
    Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit Care Med 34: 15–21PubMedCrossRefGoogle Scholar
  40. 40.
    Moerer O (2001) Cost Assessment in the ICU. Journal für Anästhesiologie und Intensivbehandlung 175–177Google Scholar
  41. 41.
    Moerer O, Burchardi H (2001) Cost profiles of direct variable costs in ICU patients. Intensive Care Med 206–206Google Scholar
  42. 42.
    Moerer O, Plock E, Mgbor U et al. (2007) A German national prevalence study on the cost of intensive care: An evaluation from 51 intensive care units. Crit Care 11: R69PubMedCrossRefGoogle Scholar
  43. 43.
    Moerer O, Schmid A, Hofmann M et al. (2002) Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 28: 1440–1446PubMedCrossRefGoogle Scholar
  44. 44.
    Neilson A, Moerer O, Burchardi H, Schneider H (2004) DRG-based reimbursement of services in German intensive care units: A new concept. Intensive Care Med 30: 1220–1223PubMedCrossRefGoogle Scholar
  45. 45.
    Neilson AR, Burchardi H, Chinn C et al. (2003) Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany. J Crit Care 18: 217–227PubMedCrossRefGoogle Scholar
  46. 46.
    Perl TM, Dvorak L, Hwang T, Wenzel RP (1995) Long-term survival and function after suspected gram-negative sepsis. JAMA 274: 338–345PubMedCrossRefGoogle Scholar
  47. 47.
    Ponce de Leon-Rosales SP, Molinar-Ramos F, Dominguez-Cherit G et al. (2000) Prevalence of infections in intensive care units in Mexico: A multicenter study. Crit Care Med 28: 1316–1321CrossRefGoogle Scholar
  48. 48.
    Quartin AA, Schein RM, Kett DH, Peduzzi PN (1997) Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 277: 1058–1063PubMedCrossRefGoogle Scholar
  49. 49.
    Rangel-Frausto MS (1999) The epidemiology of bacterial sepsis. Infect Dis Clin North Am 13: 299–312, viiPubMedCrossRefGoogle Scholar
  50. 50.
    Reinhart K (2004) Echter Fortschritt in der Intensivmedizin muss auch in Zukunft noch finanzierbar sein – Plädoyer für einen öffentlichen Diskurs. Anasthesiol Intensivmed Notfallmed Schmerzther 39: 187–190PubMedCrossRefGoogle Scholar
  51. 51.
    Reinhart K, Brunkhorst F, Bone H et al. (2006) Diagnose und Therapie der Sepsis S-2-Leitlinien der Deutschen Sepsis-Gesellschaft e.V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI). Anaesthesist 55 (Suppl 1): 43–56PubMedCrossRefGoogle Scholar
  52. 52.
    Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377PubMedCrossRefGoogle Scholar
  53. 53.
    Rubulotta F, Marshall JM, Ramsay G et al. (2009) Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med Epub ahead of print: Autor: Bitte bei Druckfahne ggfs ergänzenGoogle Scholar
  54. 54.
    Rubulotta FM, Ramsay G, Parker MM et al. (2009) An international survey: Public awareness and perception of sepsis. Crit Care Med 37: 167–170PubMedCrossRefGoogle Scholar
  55. 55.
    Sakr Y, Vincent JL, Ruokonen E et al. (2008) Sepsis and organ system failure are major determinants of post-intensive care unit mortality. J Crit Care 23: 475–483PubMedCrossRefGoogle Scholar
  56. 56.
    Sasse KC, Nauenberg E, Long A et al. (1995) Long-term survival after intensive care unit admission with sepsis. Crit Care Med 23: 1040–1047PubMedCrossRefGoogle Scholar
  57. 57.
    Schelhase T (2009) Gesundheit und soziale Sicherung. In: Datenreport 2008. Ein Sozialbericht für die Bundesrepublik Deutschland 237–260Google Scholar
  58. 58.
    Schmid A, Burchardi H, Clouth J, Schneider H (2002) Burden of illness imposed by severe sepsis in Germany. Eur J Health Econom 77–82Google Scholar
  59. 59.
    Shorr AF, Micek ST, Jackson WL, Kollef MH (2007) Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs? Crit Care Med 35: 1257–1262PubMedCrossRefGoogle Scholar
  60. 60.
    Silva E, Pedro MA, Sogayar AC et al. (2004) Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 8: R251–R260PubMedCrossRefGoogle Scholar
  61. 61.
    Sprung CL, Sakr Y, Vincent JL et al. (2006) An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study. Intensive Care Med 32: 421–427PubMedCrossRefGoogle Scholar
  62. 62.
    Sundararajan V, Macisaac CM, Presneill JJ et al. (2005) Epidemiology of sepsis in Victoria, Australia. Crit Care Med 33: 71–80PubMedCrossRefGoogle Scholar
  63. 63.
    Talmor D, Greenberg D, Howell MD et al. (2008) The costs and cost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med 36: 1168–1174PubMedCrossRefGoogle Scholar
  64. 64.
    van Gestel A, Bakker J, Veraart CP, Van Hout BA (2004) Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care 8: R153–R162CrossRefGoogle Scholar
  65. 65.
    Vincent JL, Sakr Y, Sprung CL et al. (2006) Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34: 344–353PubMedCrossRefGoogle Scholar
  66. 66.
    Welton JM, Meyer AA, Mandelkehr L et al. (2002) Outcomes of and resource consumption by high-cost patients in the intensive care unit. Am J Crit Care 11: 467–473PubMedGoogle Scholar
  67. 67.
    Weycker D, Akhras KS, Edelsberg J et al. (2003) Long–term mortality and medical care charges in patients with severe sepsis. Crit Care Med 31: 2316–2323PubMedCrossRefGoogle Scholar
  68. 68.
    Zahorec R, Firment J, Strakova J et al. (2005) Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection 33: 122–128PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2009

Authors and Affiliations

  1. 1.Zentrum Anaesthesiologie, Rettungs- und IntensivmedizinGeorg-August-Universität GöttingenGöttingenDeutschland

Personalised recommendations